Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 901–1,000 of 1,004
Testing the gene expression classification of the EMT spectrum
Jia, D., George, J. T., Tripathi, S. C., Kundnani, D. L., Lu, M., Hanash, S., Onuchic, J. N., Jolly, M. K., & Levine, H. (2018) · Physical Biology · doi:10.1088/1478-3975/aaf8d4 · Cited by 41
Hu, Y., Feng, Y., Ma, P., Wang, F., Huang, H., Guo, Y., Li, P., Mao, Q.-S., & Xue, W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.030 · Cited by 38
Wu, G., Xu, Y., Wang, Q., Li, J., Li, L., Han, C., & Xia, Q. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172637 · Cited by 40
Agbana, Y. L., Ni, Y., Zhou, M., Zhang, Q., Kassegne, K., Karou, S. D., Kuang, Y., & Zhu, Y. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.11.002 · Cited by 38
Zhao, S., & Yu, M. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5129 · Cited by 45
“Activation of EMT pathway promotes local tumor invasion and tumor cell metastasis in various cancers (De Craene and Berx, 2013; Jung et al. , 2015).”
Liu, J., Cho, Y. B., Hong, H. K., Wu, S., Ebert, P. J., Bray, S. M., Wong, S. S., Ting, J. C., Calley, J. N., Whittington, C. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67842-5 · Cited by 42
Ding, X., Zhang, J., Feng, Z., Tang, Q., & Zhou, X. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06518-6 · Cited by 39
Circulating tumor cell clusters: Insights into tumour dissemination and metastasis
Herath, S., Bazaz, S. R., Monkman, J. H., Warkiani, M. E., Richard, D. J., O'Byrne, K. J., & Kulasinghe, A. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1846523 · Cited by 39
“In the established metastatic deposits, tumour cells primarily show epithelial features hence, MET is essential to re-acquire their proliferative ability [28].”
BackgroundAbdulla, N., Vincent, C. T., & Kaur, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728325 · Cited by 45
“Transcriptional and translational controls of these TFs are governed by the expression of specific non-coding RNAs including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as well as alternative splicing and protein stability (Craene and Berx, 2013; Nieto et al., 2016).”
BackgroundAggarwal, A., Prinz-Wohlgenannt, M., Gröschel, C., Tennakoon, S., Meshcheryakova, A., Chang, W., Brown, E. M., Mechtcheriakova, D., & Kállay, E. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0330-4 · Cited by 41
“Type 3 EMT occurs during tumor progression when cancer cells exploit this mechanism to gain invasive and metastatic potential [7,8].”
BackgroundTargeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
Azmi, A. S., Muqbil, I., Wu, J., Aboukameel, A., Senapedis, W. T., Baloglu, E., Bollig-Fischer, A. B., Dyson, G. E., Kauffman, M. G., Landesman, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep16077 · Cited by 38
Chen, H., Dong, T., Li, R., Lu, J., Wei, X., & Liu, P. (2016) · Oncology Reports · doi:10.3892/or.2016.4591 · Cited by 40
Wise, R., Duhachek-Muggy, S., Qi, Y., Žółkiewski, M., & Żółkiewska, A. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3820-1 · Cited by 44
Tumour invasion and dissemination
Lusby, R., Dunne, P. D., & Tiwari, V. K. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220452 · Cited by 32
Loss of γ-cytoplasmic actin triggers myofibroblast transition of human epithelial cells
Lechuga, S., Baranwal, S., Li, C., Naydenov, N. G., Kuemmerle, J. F., Dugina, V. B., Chaponnier, C., & Ivanov, A. I. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0815 · Cited by 41
Fan, Z., Jiang, H., Wang, Z., & Qu, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4897 · Cited by 41
Xu, N., Chen, H., Chen, S., Xue, X., Chen, H., Zheng, Q., Wei, Y., Li, X., Huang, J., Cai, H., et al. (2016) · Medicine · doi:10.1097/md.0000000000004326 · Cited by 37
Dinicola, S., Masiello, M. G., Proietti, S., Coluccia, P., Fabrizi, G., Catizone, A., Ricci, G., Toma, G. D., Bizzarri, M., & Cucina, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26323 · Cited by 37
“However, EMT occurs also during different pathological processes contributing to cancer invasion and metastasis of many different solid tumors of epithelial origin, including colon cancer (Bates, Pursell, & Mercurio, 2007; De Craene & Berx, 2013).”
BackgroundChen, B., Li, Q., Zhou, Y., Wang, X., Zhang, Q., Wang, Y., Zhuang, H., Jiang, X., & Xiong, W. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1496741 · Cited by 37
“For example, AFAP1-AS1 expression was increased in esophageal squamous cell carcinoma (ESCC) and knockdown of AFAP1-AS1 in ESCC cells suppressed cell proliferation and colony formation and induced cell apoptosis [38,39].”
BackgroundTGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma
Tretbar, S., Krausbeck, P., Müller, A., Friedrich, M., Vaxevanis, C., Bukur, J., Jasinski‐Bergner, S., & Seliger, B. (2019) · Oncotarget · doi:10.18632/oncotarget.26682 · Cited by 42
Crosslinking catalytic hairpin assembly for high-contrast imaging of multiple mRNAs in living cells
Huang, D.-J., Cao, T., Huang, Z., Wu, Z., Tang, L., & Jiang, J. (2019) · Chemical Communications · doi:10.1039/c9cc01033e · Cited by 37
Ling, Z., Yang, X., Chen, X., Xia, J., Cheng, B., & Tao, X. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12869 · Cited by 37
Liu, J., Liu, S., Deng, X., Rao, J., Huang, K., Xu, G., & Wang, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217652 · Cited by 37
Dou, C., Sun, L., Wang, L., Cheng, J. G., Wu, W., Zhang, C., Xu, Q., Tu, K., & Liu, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02943-7 · Cited by 39
Ebata, N., Fujita, M., Sasagawa, S., Maejima, K., Okawa, Y., Hatanaka, Y., Mitsuhashi, T., Oosawa, A., Tanaka, H., Miyano, S., et al. (2021) · Cancers · doi:10.3390/cancers13040733 · Cited by 37
“Alteration of the TGF-β signaling pathway induces EMT and increases tumor aggressiveness and is central to immune suppression within TME [14,41].”
BackgroundMicroRNAs as a clue to overcome breast cancer treatment resistance
Garrido‐Cano, I., Pattanayak, B., Adam‐Artigues, A., Lameirinhas, A., Torres‐Ruiz, S., Tormo, E., Cervera, R., & Eroles, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09992-0 · Cited by 42
“There are different molecules involved in the induction of EMT, including Snail Family Transcriptional Repressor 1 (SNAI1), ZEB1/2, Twist Family BHLH Transcription Factor 1/2 (TWIST1/2) [194, 195], and some growth factors such as Transforming Growth Factor-beta (TGF-β), EGF, and Tumor Necrosis Factor-alpha (TNFα) [193…”
BackgroundmicroRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells
Mortoglou, M., Miralles, F., Arısan, E. D., Dart, D. A., Jurčević, S., Lange, S., & Onganer, P. U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031275 · Cited by 38
“EMT is regulated via molecular pathways linked to oncogenic and tumor suppressor non-coding RNAs, chromatin remodeling, epigenetic and posttranslational modifications, alternative splicing events, and protein stability [51,52].”
BackgroundBMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1
Wang, Q., Wu, Y., Lin, M., Wang, G., Liu, J., Xie, M., Zheng, B. J., Shen, C., & Shen, J. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02552-8 · Cited by 38
“Wu HT, Zhong HT, Li GW, et al. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.”
BackgroundInfluentialZhang, X., Wang, J., Liu, N., Wu, W., Li, H., Chen, J., & Guo, X. Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-4267 · Cited by 40
“The expression of EMT transcription factors SNAIL1 and ZEB1 , the downstream molecules of AKT pathway, increased, and the expression of mesothelial marker VIM .”
InfluentialImmunohistochemical analysis of the expression of E ‐cadherin and ZEB1 in non‐small cell lung cancer
Matsubara, D., Kishaba, Y., Yoshimoto, T., Sakuma, Y., Sakatani, T., Tamura, T., Endo, S., Sugiyama, Y., Murakami, Y., & Niki, T. (2014) · Pathology International · doi:10.1111/pin.12214 · Cited by 37
Yu, H., Xiang, P., Pan, Q., Huang, Y., Xie, N., & Zhu, W. (2016) · Tumor Biology · doi:10.1007/s13277-016-5020-3 · Cited by 37
“If the cancer cell has acquired the necessary genetic aberrations and receives the appropriate signals, the dissemination of tumor cells from the solid tumor after breakdown of the basement membrane can be achieved [29].”
Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
Che, K., Zhao, Y., Qu, X. H., Pang, Z., Ni, Y., Zhang, T., Du, J., & Shen, H. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s127762 · Cited by 37
“As for the biological significance of tumor budding, investigators have noted that this process may be associated with epithelial–mesenchymal transition (EMT), thereby increasing cancer cell migration and invasion.(14,15) Tumor budding is considered an indicator of EMT in the tumor microenvironment.”
Garreau, M., Weidner, J., Hamilton, R. S., Kołosionek, E., Toki, N., Stavenhagen, K., Paris, C., Bonetti, A., Czechtizky, W., Gnerlich, F. A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae141 · Cited by 40
“As our model miRNA, we chose hsa-miR-200c-3p (miR-200c), which has been widely investigated in cancer, particularly in the context of epithelial-mesenchymal transition (EMT) ( 27 ,28 ).”
MethodGenetics of breast cancer bone metastasis: a sequential multistep pattern
Fazilaty, H., & Mehdipour, P. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9642-9 · Cited by 39
Göttgens, E., Span, P. N., & Zegers, M. M. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.06.003 · Cited by 40
Kaller, M., & Hermeking, H. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_4 · Cited by 37
Yang, D., Cao, X., Wang, F., Jiang, H., Feng, D., Guo, H., Du, L., Jin, Y., Chen, Y., Yin, X., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.035 · Cited by 36
The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
Contreras, H. R., Orellana‐Serradell, O., Herrera, D., & Castellón, E. A. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_61_17 · Cited by 36
USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2
Ouchida, A. T., Kacal, M., Zheng, A., Ambroise, G., Zhang, B., Norberg, E., & Vakifahmetoglu-Norberg, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.156 · Cited by 40
“Accordingly, EMT has been shown to occur in wound healing studies and during the initiation of metastasis of cancer cells [1,2] by reversibly changing the expression of proteins involved in cell polarity, cellecell contact, cytoskeleton structure and extracellular matrix degradation, including the repression of key ep…”
BackgroundAlidadiani, N., Ghaderi, S., Dilaver, N., Bakhshamin, S., & Bayat, M. (2018) · Gene · doi:10.1016/j.gene.2018.06.049 · Cited by 39
Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression
Narayan, S. S., Lorenz, K., Ukkat, J., Hoang‐Vu, C., & Trojanowicz, B. (2019) · Neoplasma · doi:10.4149/neo_2019_190506n405 · Cited by 39
“Furthermore, ACE and ACE2 may act as important components of tumor microenvironment and by interaction with different adhesion-related factors, such as E-cadherin [16] or cytokines, such as TGFb [17], are able to modulate the epithelial-to-mesenchymal transformation [18], crucial for processes of neoplasia [19].”
BackgroundPan, J., Xu, X., & Wang, G. (2020) · Cancer Management and Research · doi:10.2147/cmar.s237439 · Cited by 36
Fan, J., Li, Y., Wei, Z., Fan, Y., Li, X.-D., Chen, Z., Hou, D., Xiao, W., Ding, M.-R., Wang, H., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01950 · Cited by 36
Contribution of adrenergic mechanisms for the stress‐induced breast cancer carcinogenesis
Silva, D., Quintas, C., Gonçalves, J., & Fresco, P. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30707 · Cited by 39
The therapeutic potential of targeting the epithelial–mesenchymal transition in cancer
Ginnebaugh, K. R., Ahmad, A., & Sarkar, F. H. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.909807 · Cited by 38
“These cell--cell dissociations occur through transcriptional downregulation of adhesion components and maintenance pathways, post-translational modifications that cause destabilization of the cellular complex and protease activation of structural components [44].”
BackgroundTian, H., Ge, C., Zhao, F., Zhu, M., Zhang, L., Huo, Q., Li, H., Chen, T., Xie, H., Cui, Y., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw125 · Cited by 38
Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes
Scott, M. L., Coleman, D. T., Kelly, K. C., Carroll, J. L., Woodby, B., Songock, W. K., Cardelli, J. A., & Bodily, J. M. (2018) · Virology · doi:10.1016/j.virol.2018.03.021 · Cited by 35
“Cell motility induced by HGF/Met in cell culture resembles an epithelial-to-mesenchymal transition (EMT), which is often a precursor to metastasis (Boccaccio and Comoglio, 2006; Craene and Berx, 2012; Drake and Macleod, 2014; Hanahan and Weinberg, 2011; Steffan et al., 2011; Thiery and Sleeman, 2006).”
BackgroundThe tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer
Antony, J., Zanini, E., Kelly, Z., Tan, T. Z., Karali, E., Alomary, M. N., Jung, Y., Nixon, K., Cunnea, P., Fotopoulou, C., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745670 · Cited by 38
“Gas6 induced the phosphorylation of AXL leading to sustained activation of ERK for up to 24 h (Fig 3A and B) and the induction of the EMT transcription factor Slug, a key factor in cell motility and invasiveness [19,20] (Fig 3A and B).”
Tissue and plasma proteomics for early stage cancer detection
Peng, L., Cantor, D. I., Huang, C., Wang, K., Baker, M. S., & Nice, E. C. (2018) · Molecular Omics · doi:10.1039/c8mo00126j · Cited by 42
Jiang, Y., Cheng, H., Kuo, C., Way, T., Lien, J., Chueh, F., Lin, Y., & Chung, J. (2018) · Environmental Toxicology · doi:10.1002/tox.22691 · Cited by 37
Engaging plasticity: Differentiation therapy in solid tumors
Bar-Hai, N., & Ishay-Ronen, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944773 · Cited by 35
“Computational and experimental analysis have examined the dynamics of the regulatory networks involved in EMT and discovered the importance of feedback loops (Brabletz and Brabletz, 2010; Siemens et al., 2011; Craene and Berx, 2013; Lu et al., 2013; Tian et al., 2013; Shi et al., 2014; Jolly et al., 2015a; Jolly et al…”
BackgroundChaotham, C., Pongrakhananon, V., Sritularak, B., & Pithi Chanvorachote, B. (2014) · PubMed · Cited by 36
Zhang, F., Zhang, X., Meng, J., Zhao, Y., Liu, X., Liu, Y., Wang, Y., Li, Y., Sun, Y., Wang, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3842 · Cited by 35
“The epithelial-to-mesenchymal transition (EMT) has been proved to play a critical role in driving tumor invasion and metastasis [14].”
Zhao, Q., Yue, J., Zhang, C., Gu, X., Chen, H., & Xu, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5004 · Cited by 36
“The expression of these EMT master regulators is modulated by numerous signaling molecules, including nuclear factor κB (NF-κB) [12,16–18].”
BackgroundBowe, R. A., Cox, Ó. T., Ayllón, V., Tresse, E., Healy, N. C., Edmunds, S. J., Huigsloot, M., & O’Connor, R. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-06-0306 · Cited by 37
“PDLIM2 may now be added to a small group of LIM-domain proteins that regulate phenotypic changes in cancer progression (Craene and Berx, 2013).”
BackgroundRen, J., Yu, S., Gao, N., & Zou, Q. (2013) · Physical Review E · doi:10.1103/physreve.88.052711 · Cited by 35
Costabile, V., Duraturo, F., Delrio, P., Rega, D., Pace, U., Liccardo, R., Rossi, G. B., Genesio, R., Nitsch, L., Izzo, P., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2911 · Cited by 37
Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation
Pagliarini, V., Naro, C., & Sette, C. (2015) · BioMed Research International · doi:10.1155/2015/543067 · Cited by 38
Fici, P., Gallerani, G., Morel, A., Mercatali, L., Ibrahim, T., Scarpi, E., Amadori, D., Puisieux, A., Rigaud, M., & Fabbri, F. (2016) · Oncotarget · doi:10.18632/oncotarget.13682 · Cited by 39
“com/oncotarget At the molecular level, gene expression analysis confirmed that the transition was ongoing in our cell models and started before morphological events took place, in agreement with other studies [18, 30].”
BackgroundResultLi, L., Gu, X., Yue, J., Zhao, Q., Lv, D., Chen, H., & Xu, L. (2017) · Oncotarget · doi:10.18632/oncotarget.21170 · Cited by 37
ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer
Li, R., Zhuang, C., Jiang, S., Du, N., Zhao, W., Tu, L., Cao, H., Zhang, Z., & Chen, X. (2017) · Journal of Cancer · doi:10.7150/jca.20900 · Cited by 38
“EMT is critical for multiple pathophysiological processes, especially tumorigenesis and progression [20].”
BackgroundPassacantilli, I., Panzeri, V., Bielli, P., Farini, D., Pilozzi, E., Fave, G. D., Capurso, G., & Sette, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.562 · Cited by 35
“However, it can be re-activated upon neoplastic transformation of epithelial cells, permitting them to reach distal tissues and to give rise to metastasis.(5,6) In PDAC mouse models, EMT allows dissemination of cancer cells even before the primary tumor is fully visualized.”
BackgroundWeingarten, C., Jenudi, Y., Tshuva, R. Y., Moskovich, D., Alfandari, A., Hercbergs, A. A., Davis, P. J., Ellis, M. H., & Ashur‐Fabian, O. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0316-3 · Cited by 40
“Epithelial-mesenchymal transition (EMT) is a biological process that is essential to driving plasticity during embryonic development and to cancer invasiveness and metastasis [3], including these functions in ovarian cancer [4, 5].”
BackgroundJin, Y., Wu, D., Yang, W., Weng, M., Li, Y., Wang, X., Zhang, X. L., Jin, X., & Wang, T. (2017) · Virology Journal · doi:10.1186/s12985-017-0903-5 · Cited by 35
“Epithelial-mesenchymal transition (EMT) is an important mechanism for cancer metastasis and recurrence [8].”
BackgroundWang, X., Qiu, H., Tang, R., Song, H., Pan, H., Feng, Z., & Chen, L. (2018) · Oncology Reports · doi:10.3892/or.2018.6379 · Cited by 47
“Epithelial-mesenchymal transition (EMT), characterized by the loss of epithelial characteristics and the acquisition of mesenchymal phenotype, plays an important role in cancer invasion and metastasis (13).”
Shu, X., Liu, H., Pan, Y., Sun, L., Yu, L., Sun, L., Yang, Z., & Ran, Y. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03548-1 · Cited by 36
Liu, M., Hancock, S. E., Sultani, G., Wilkins, B. P., Ding, E., Osborne, B., Quek, L., & Turner, N. A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060822 · Cited by 37
“In response to EMT-inducing signals commonly existing in the tumor micro-environment, a network of intracellular pathways is activated to convey the message to the EMT executioners for transcriptional regulation [6].”
BackgroundThe histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma
Poté, N., Cros, J. F., Laouirem, S., Raffenne, J., Negrão, M., Albuquerque, M., Bédossa, P., Ferreira, M. G., Ait‐Si‐Ali, S., Fior, R., et al. (2020) · Liver International · doi:10.1111/liv.14381 · Cited by 39
“As expected, H4K16ac was significantly increased in HCC/ mVI + compared to HCC/mVI− (mean score 100 [69-131] vs 28 [12-40]; P = .”
ResultXu, Z., Zhou, Z., Zhang, J., Xuan, F., Fan, M., Zhou, D., Liuyang, Z., Ma, X., Hong, Y., Wang, Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.018 · Cited by 37
circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p
Dong, Y., Qiu, T., Xuan, Y., Liu, A., Sun, X., Huang, Z., Su, W., Du, W., Yun, T., Wo, Y., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-230 · Cited by 37
“In tumor metastasis (16), as opposed to having normal characteristics, such as intercellular adhesion and cell polarity, the epithelial cells are characterized by altered shape, increased motility, invasive properties, and migratory potential, all of which represent a mesenchymal phenotype caused by EMT (17).”
BackgroundBiophysical interactions between components of the tumor microenvironment promote metastasis
Vasilaki, D., Bakopoulou, A., Tsouknidas, A., Johnstone, E. C., & Michalakis, K. X. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00811-y · Cited by 40
The role of autophagy in pancreatic cancer progression
Wang, Y., Qin, C., Yang, G., Zhao, B., & Wang, W. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188592 · Cited by 36
Tuerhong, A., Xu, J., Shi, S., Tan, Z., Meng, Q., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03866-y · Cited by 39
Liu, G., Liu, R., Shan, Y., & Sun, C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101133 · Cited by 36
“EMT refers to a global cellular and molecular transition during tumor metastasis, by which polarized epithelial cells gain mesenchymal properties to migrate (14, 29).”
E-cadherin on epithelial–mesenchymal transition in thyroid cancer
Zhu, X., Wang, X., Gong, Y., & Deng, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02344-6 · Cited by 39
“In the related studies of tumors, it has been shown that the malignant expression, metastasis and invasiveness of tumors are all related to epithelial– mesenchymal transition (EMT) [3].”
BackgroundCastellón, E. A., Indo, S., & Contreras, H. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314917 · Cited by 39
Meseure, D., Alsibai, K. D., & Nicolas, A. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0158-2 · Cited by 37
Vitamin D and its receptor during late development
Goltzman, D., Hendy, G. N., & White, J. H. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.026 · Cited by 39
“Transcription factors, including those belonging to the SNAIL family, coordinate EMT by repressing CDH1 (encoding E-cadherin) and other epithelial cell junction proteins [31].”
BackgroundCo-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival
Kong, Y. H., Zanaruddin, S. N. S., Lau, S. H., Ramanathan, A., Kallarakkal, T. G., Vincent–Chong, V. K., Mustafa, W. M. W., Abraham, M. T., Rahman, Z. A. A., Zain, R. B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134045 · Cited by 36
“EMT occurrence demonstrated by the expression of EMT-associated proteins as described above has been reported for many different cancer types including head and neck cancer [3, 4, 8].”
BackgroundBiology and clinical significance of circulating tumor cell subpopulations in lung cancer
O′Flaherty, L., Wikman, H., & Pantel, K. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.07.03 · Cited by 37
“This transition is referred to as an epithelial-mesenchymal transition (EMT) and is often associated with tumor aggressiveness and resistance to therapeutic intervention (25,26).”
BackgroundLin, H., Hao, Y., Wan, X., He, J., & Tong, Y. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1713807 · Cited by 35
“The early EMT transcription factors, like Snail, Slug and Twist, inhibit the expression of epithelial cells and enhance the motility of transformed mesenchymal cells, while the up-regulation of MMP-2 and MMP-9 contributes to this process [29,30].”
BackgroundZhao, B., Liu, L., Mao, J., Zhang, Z., Wang, Q., & Li, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03387-3 · Cited by 36
RNF8 Promotes Epithelial–Mesenchymal Transition in Lung Cancer Cells via Stabilization of Slug
Kuang, J., Lu, M., Liu, C., Chen, S., Gao, C., Ma, J., Wu, X., Li, W., Wu, L., & Zhu, L. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1211 · Cited by 39
Mierke, C. T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1130823 · Cited by 44
“These complex metastatic staging processes are coordinated through a set of EMT-TFs that have been comprehensively explored (Craene and Berx, 2013; Lamouille et al., 2014).”
BackgroundIshimoto, T., Baba, H. A., Izumi, D., Sugihara, H., Kurashige, J., Iwatsuki, M., & Tan, P. B. O. (2015) · International Journal of Cancer · doi:10.1002/ijc.29627 · Cited by 34
“A number of miRNAs have been associated with the EMT phenotype in various types of cancer, including GC.(83) The expression of miR-7 is significantly downregulated in highly metastatic GC cell lines and metastatic tissues.”
BackgroundBendinelli, P., Maroni, P., Matteucci, E., & Desiderio, M. A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0389-y · Cited by 35
“The data show different effects of HGF and TGFβ1 on Twist and Snail patterns in nuclei, important for their transcription factor activity [7], and also differences in the relationship with Wwox phosphorylation.”
BackgroundRetractedPerrot, C. Y., Gilbert, C., Marsaud, V., Postigo, A. A., Javelaud, D., & Mauviel, A. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12149 · Cited by 40
“We identified GLI2 as a direct transcriptional target of the TGF-b/SMAD pathway, leading to Hedgehog-independent activation of GLI1 and associated biological responses (Dennler et al., 2007, 2009).”
BackgroundLee, Y., Ko, D., Min, H.-J., Kim, S. B., Ahn, H.-M., Lee, Y., & Kim, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10382 · Cited by 34
Ramamurthy, V. P., Ramalingam, S., Gediya, L. K., & Njar, V. C. O. (2018) · FEBS Journal · doi:10.1111/febs.14383 · Cited by 34
Vakili‐Ghartavol, R., Mombeiny, R., Salmaninejad, A., Rezayat, S. M., Majidi, R. F., Jaafari, M. R., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27027 · Cited by 35
“Nonetheless, miR‐21 is the most regulated miRNA in solid tumors and a potent inducer of EMT (Coppola et al., 2013; Craene & Berx, 2013; Sekhon, Bucay, Majid, Dahiya, & Saini, 2016).”
BackgroundInfluentialMicroRNAs and signaling networks involved in epithelial–mesenchymal transition
Shenas, M. H. M., Eghbal‐Fard, S., Mehrisofiani, V., Yazdani, N. A., Farzam, O. R., Marofi, F., & Yousefi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27489 · Cited by 36
“In complicated diseases like cancers, several miRNAs are involved (Craene & Berx, 2013).”
BackgroundDCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer
Makino, S., Takahashi, H., Okuzaki, D., Miyoshi, N., Haraguchi, N., Hata, T., Matsuda, C., Yamamoto, H., Mizushima, T., Mori, M., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz157 · Cited by 36
Abdullah, N. A., Hashim, N. F. M., Ammar, A., & Zakuan, N. M. (2021) · Molecules · doi:10.3390/molecules26040775 · Cited by 37
“The shift from one stat to another is controlled by a range of growth factors and signaling pathways [47].”
BackgroundLiu, W., Wang, B., Duan, A., Shen, K., Zhang, Q., Tang, X., Wei, Y., Tang, J. X., & Zhang, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02257-4 · Cited by 35
The Role of NcRNAs to Regulate Immune Checkpoints in Cancer
Jiang, Y., Zhao, L., Wu, Y., Deng, S., Cao, P., Lei, X., & Yang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853480 · Cited by 35
An Update to Hallmarks of Cancer
Ravi, S., Alencar, A. M., Arakelyan, J., Xu, W., Stauber, R., Wang, C.-C. I., Papyan, R., Ghazaryan, N. A., & Pereira, R. M. (2022) · Cureus · doi:10.7759/cureus.24803 · Cited by 48
“In recent years, there has been a vital debate on whether EMT features a central role in cancer metastasis and resistance to chemotherapy [157].”
BackgroundQi, X. (2022) · American Journal of Cancer Research · doi:10.62347/etjh6697 · Cited by 34
Andersen, R. K., Hammer, K., Hager, H., Christensen, J. N., Ludvigsen, M., Honoré, B., Thomsen, M. H., & Madsen, M. M. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12352 · Cited by 38
Dynamic cohesin‐mediated chromatin architecture controls epithelial–mesenchymal plasticity in cancer
Yun, J., Song, S., Kim, H., Han, S., Yi, E. C., & Kim, T. (2016) · EMBO Reports · doi:10.15252/embr.201541852 · Cited by 35
“Over the past few decades, many groups have studied EMT and EMT-related genes such as E-cadherin (CDH1), vimentin (VIM), tumor growth factor b (TGFB), twist-related protein 1 (TWIST1), b-catenin (CTNNB1), zinc finger E-box-binding homeobox 1/2 (ZEB1/2), and the miR200 family [10].”
Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition
Al‐Hattab, D. S., Safi, H. A., Nagalingam, R. S., Bagchi, R. A., Stecy, M. T., & Czubryt, M. P. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00092.2018 · Cited by 35
“Together, these transcription factors mediate the changes in gene expression that contribute to repression of the epithelial phenotype and induction of the mesenchymal phenotype (11).”
Background
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.